Comparison of insulin detemir and insulin glargine in a basal—bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial
- 31 October 2009
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 31 (10), 2086-2097
- https://doi.org/10.1016/j.clinthera.2009.10.006
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk
This publication has 19 references indexed in Scilit:
- Comparison of Once- Versus Twice-Daily Administration of Insulin Detemir, Used With Mealtime Insulin Aspart, in Basal-Bolus Therapy for Type 1 DiabetesDiabetes Care, 2009
- Refining basal insulin therapy: what have we learned in the age of analogues?Diabetes/Metabolism Research and Reviews, 2007
- Towards peakless, reproducible and long‐acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studiesDiabetes, Obesity and Metabolism, 2007
- Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapyDiabetic Medicine, 2007
- Albumin‐bound basal insulin analogues (insulin detemir and NN344): comparable time‐action profiles but less variability than insulin glargine in type 2 diabetesDiabetes, Obesity and Metabolism, 2006
- Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargineDiabetes Research and Clinical Practice, 2004
- The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human InsulinPharmaceutical Research, 2004
- Variability of Insulin Absorption and Insulin ActionDiabetes Technology & Therapeutics, 2002
- Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pensThe Lancet, 1999
- A desktop guide to Type 1 (insulin‐dependent) diabetes mellitusDiabetic Medicine, 1999